"Neoplasm Metastasis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
| Descriptor ID |
D009362
|
| MeSH Number(s) |
C04.697.650 C23.550.727.650
|
| Concept/Terms |
Neoplasm Metastasis- Neoplasm Metastasis
- Metastases, Neoplasm
- Neoplasm Metastases
- Metastasis
- Metastases
- Metastasis, Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Metastasis".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Metastasis".
This graph shows the total number of publications written about "Neoplasm Metastasis" by people in this website by year, and whether "Neoplasm Metastasis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 4 | 4 |
| 1998 | 1 | 7 | 8 |
| 1999 | 0 | 2 | 2 |
| 2000 | 2 | 2 | 4 |
| 2001 | 0 | 11 | 11 |
| 2002 | 1 | 10 | 11 |
| 2003 | 1 | 7 | 8 |
| 2004 | 0 | 13 | 13 |
| 2005 | 4 | 10 | 14 |
| 2006 | 1 | 5 | 6 |
| 2007 | 1 | 15 | 16 |
| 2008 | 2 | 10 | 12 |
| 2009 | 6 | 15 | 21 |
| 2010 | 5 | 22 | 27 |
| 2011 | 3 | 19 | 22 |
| 2012 | 4 | 14 | 18 |
| 2013 | 8 | 19 | 27 |
| 2014 | 1 | 18 | 19 |
| 2015 | 1 | 30 | 31 |
| 2016 | 4 | 23 | 27 |
| 2017 | 1 | 22 | 23 |
| 2018 | 4 | 21 | 25 |
| 2019 | 2 | 17 | 19 |
| 2020 | 4 | 16 | 20 |
| 2021 | 4 | 17 | 21 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
| 2024 | 4 | 10 | 14 |
| 2025 | 2 | 22 | 24 |
| 2026 | 0 | 7 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Metastasis" by people in Profiles.
-
Targeted suppression of SPP1 inhibits tumor invasion and metastasis in NRF2 hyperactivated cisplatin resistant HNSCC. J Transl Med. 2026 May 22; 24(1).
-
Unbiased niche labeling maps immune-excluded niche in bone metastasis. Cell. 2026 May 28; 189(11):3287-3305.e25.
-
Loss of luminal lineage drives resistance to next-generation ERa antagonists in pretreated ER+ HER2- locally-advanced or metastatic breast cancer. Nat Commun. 2026 Apr 01; 17(1).
-
Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State. Clin Lung Cancer. 2026 May; 27(4):14-23.
-
MiR-200c restoration inhibits FOXP3 and metastatic spread in breast cancer: evidence from in vitro and in vivo models. BMC Cancer. 2026 Feb 14; 26(1).
-
Extracellular matrix mediates circulating tumor cell clustering in triple-negative breast cancer metastasis. Nat Commun. 2026 Feb 06; 17(1):1352.
-
KRAS-ERK signaling drives metastasis in colorectal cancer via phosphorylation-dependent activation of the ZBTB20-TGFBR2 axis. J Exp Clin Cancer Res. 2026 Jan 02; 45(1):29.
-
Surface Marker Identification to Capture Live Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer. Cancer Res Commun. 2026 01 01; 6(1):115-129.
-
A Spatiotemporal Model of CXCL10 as a Master Regulator of Immune Evasion and Metastasis in Osteosarcoma. Int J Mol Sci. 2025 Dec 27; 27(1).
-
Forward genetic screening in engineered colorectal cancer organoids identifies regulators of metastasis. Proc Natl Acad Sci U S A. 2025 Nov 18; 122(46):e2510910122.